Creative Biolabs has expanded its research and development services for extracellular vesicles (EVs) derived from edible plants, the company announced. The move comes as plant-derived EVs, including exosome-like nanovesicles, are increasingly investigated as alternative nanoscale delivery systems due to their natural origin, potential scalability, and reported biocompatibility in experimental models.
The company now offers custom services covering the entire experimental pipeline: isolation and purification of crude plant extracts, multi-dimensional characterization using nanoparticle tracking analysis, transmission electron microscopy, and western blotting, experimental cargo loading with small molecules, siRNAs, and peptides, and subsequent in vitro and in vivo biological activity assessments. These services are designed to support researchers investigating plant-derived vesicles as biological nanoparticles and experimental delivery systems.
Plant-derived EVs have attracted interest because experimental studies have reported favorable biocompatibility and interactions with biological barriers, though these properties depend heavily on vesicle source, composition, preparation, and the experimental model. Their endogenous cargos—including small RNAs, specific lipids, and secondary metabolites—are being investigated for potential biological activity, while the vesicles themselves are also explored as delivery vehicles.
To support diverse research applications, Creative Biolabs provides tailored services for EVs from specific plant sources. For skin biology and tissue-repair research, Strawberry-derived EVs are being investigated in oxidative-stress, skin biology, and tissue-repair research, including studies examining antioxidant-associated cargos and cellular responses relevant to extracellular-matrix biology. For oral delivery and gastrointestinal research, Grapefruit-derived EVs have been investigated for oral-delivery applications, including studies of vesicle stability under gastrointestinal conditions and their potential use as experimental carriers for intestinal delivery. For inflammation, microbial, and immune research, Garlic-derived EVs are being studied for their molecular cargo and potential effects on inflammatory, microbial, and immune-related pathways.
“Plant-derived extracellular vesicles are attracting growing research interest because their composition and biological properties can vary substantially across plant sources,” stated a scientist at Creative Biolabs. “A systematic workflow for isolation, characterization, cargo loading, and functional evaluation can help researchers compare these vesicles and investigate their potential in different experimental applications.”
The expansion matters because it addresses a key bottleneck in the field: the lack of standardized, comprehensive workflows for plant-derived EV research. By offering end-to-end support, Creative Biolabs aims to accelerate studies that could lead to new experimental delivery systems and bioactive compounds. For more information, visit https://www.creative-biolabs.com/exosome/.
The services are for research use only and are not intended for diagnostic or therapeutic procedures.
